These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Kageyama K, Hanada K, Moriyama T, Imaizumi T, Satoh K, Suda T. Mol Cell Endocrinol; 2007 Jan 15; 263(1-2):90-102. PubMed ID: 17027144 [Abstract] [Full Text] [Related]
23. Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Huang Q, Rivest R, Richard D. Endocrinology; 1998 Apr 15; 139(4):1524-32. PubMed ID: 9528930 [Abstract] [Full Text] [Related]
25. Regulation of the expression of corticotropin-releasing factor gene by pyroglutamylated RFamide peptide in rat hypothalamic 4B cells. Ishigame N, Kageyama K, Takayasu S, Furumai K, Nakada Y, Daimon M. Endocr J; 2016 Oct 29; 63(10):919-927. PubMed ID: 27452579 [Abstract] [Full Text] [Related]
26. Corticotrophin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. Kageyama K, Akimoto K, Suda T. J Neuroendocrinol; 2010 Sep 29; 22(9):971-8. PubMed ID: 20626567 [Abstract] [Full Text] [Related]
27. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. J Comp Neurol; 1999 Dec 20; 415(3):285-312. PubMed ID: 10553117 [Abstract] [Full Text] [Related]
28. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis. Dermitzaki E, Tsatsanis C, Gravanis A, Margioris AN. J Cell Physiol; 2012 May 20; 227(5):1861-72. PubMed ID: 21702050 [Abstract] [Full Text] [Related]
29. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. J Pharmacol Exp Ther; 1996 Oct 20; 279(1):351-8. PubMed ID: 8859013 [Abstract] [Full Text] [Related]
30. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres. Henry BA, Lightman SL, Lowry CA. J Neuroendocrinol; 2005 Mar 20; 17(3):135-44. PubMed ID: 15796765 [Abstract] [Full Text] [Related]
31. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. Kageyama K, Hanada K, Iwasaki Y, Sakihara S, Nigawara T, Kasckow J, Suda T. J Endocrinol; 2007 Nov 20; 195(2):199-211. PubMed ID: 17951532 [Abstract] [Full Text] [Related]
32. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Kageyama K, Kumata Y, Akimoto K, Takayasu S, Tamasawa N, Suda T. Stress; 2011 Sep 20; 14(5):520-9. PubMed ID: 21438782 [Abstract] [Full Text] [Related]
33. Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice. Duan J, Choi YH, Hartzell D, Della-Fera MA, Hamrick M, Baile CA. Obesity (Silver Spring); 2007 Nov 20; 15(11):2624-33. PubMed ID: 18070753 [Abstract] [Full Text] [Related]
34. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7570-5. PubMed ID: 11416224 [Abstract] [Full Text] [Related]
35. Oestradiol modulates the effects of leptin on energy homeostasis by corticotrophin-releasing factor type 2 receptor. Marangon PB, Silva LE, Rorato R, Gomiero Alves P, Antunes-Rodrigues J, Elias LL. J Neuroendocrinol; 2014 Nov 19; 26(11):796-804. PubMed ID: 25113140 [Abstract] [Full Text] [Related]
36. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szücs A, Koob GF, Zorrilla EP. Neuropsychopharmacology; 2007 May 19; 32(5):1052-68. PubMed ID: 17019404 [Abstract] [Full Text] [Related]
37. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression. Lee S, Smith GW, Vale W, Lee KF, Rivier C. Alcohol Clin Exp Res; 2001 Mar 19; 25(3):427-33. PubMed ID: 11290855 [Abstract] [Full Text] [Related]
38. Unexpected amplification of leptin-induced Stat3 signaling by urocortin: implications for obesity. Pan W, Tu H, Hsuchou H, Daniel J, Kastin AJ. J Mol Neurosci; 2007 Mar 19; 33(3):232-8. PubMed ID: 17952632 [Abstract] [Full Text] [Related]
39. Corticotropin-releasing factor overexpression in mice abrogates sex differences in body weight, visceral fat, and food intake response to a fast and alters levels of feeding regulatory hormones. Wang L, Goebel-Stengel M, Yuan PQ, Stengel A, Taché Y. Biol Sex Differ; 2017 Mar 19; 8():2. PubMed ID: 28101317 [Abstract] [Full Text] [Related]
40. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C. Nature; 1995 Nov 16; 378(6554):287-92. PubMed ID: 7477349 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]